Entering text into the input field will update the search result below

Veracyte, Inc. (VCYT) CEO Marc Stapley on Q1 2022 Results - Earning Calls Transcript

May 03, 2022 8:49 PM ETVeracyte, Inc. (VCYT)
SA Transcripts profile picture
SA Transcripts

Veracyte, Inc. (NASDAQ:VCYT) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET

Company Participants

Marc Stapley – Chief Executive Officer

Rebecca Chambers – Chief Financial Officer

Giulia Kennedy – Chief Scientific & Medical Officer

Tina Nova – General Manager of Thyroid & Urologic Cancer

Sheila Goldman – Director of Investor Relations

Conference Call Participants

Brian Weinstein – William Blair

David Hein – Goldman Sachs

Mason Carrico – Stephens Inc.

Tejas Savant – Morgan Stanley

Paul Knight – KeyBanc

Joseph Stringer – Needham & Company

Puneet Souda – SVB Securities


Good afternoon, ladies and gentlemen, and welcome to Veracyte's First Quarter 2022, financial results conference call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press [Operator's Instruction] on your touch tone telephone. If anyone should require assistance during the conference, please press [Operator Instructions]. As a reminder, today's conference call is being recorded. I'd now like to turn the conference over to Sheila Goldman, their sites Director of Investor Relations. You may begin.

Sheila Goldman

Good afternoon, everyone. And thanks for joining us today for a discussion of our first quarter 2022 financial results. With me today are Marc Stapley, Veracyte's Chief Executive Officer. Rebecca Chambers, our Chief Financial Officer, Dr. Tina Nova, President of our U.S. CLIA business, and Dr. Giulia Kennedy, Global Chief Scientific Officer and Chief Medical Officer. Veracyte issued a press release earlier this afternoon detailing our first quarter 2022 financial results. This news release, along with a business and financial presentation, is available in the Investor Relations section of our website at Veracyte.com.

Before we begin, I'd like to remind you that various statements that we may make during this call

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.